Man fined for illegal sale of poisonous e-cigarette liquid.

Nov.17.2022
Man fined for illegal sale of poisonous e-cigarette liquid.
A man in Kota Kinabalu, Malaysia was fined RM3500 or three months imprisonment for selling 237 bottles of toxic e-cigarette liquid.

A 36-year-old man in Kota Kinabalu, the capital of Malaysia's Sabah state, has been fined RM3,500 (approximately RMB 5,471) or sentenced to three months' imprisonment for selling 237 bottles of poisonous e-cigarette liquid without a license four years ago.


A man named Abdul Gafoor Hasanudeen has admitted to selling 57 flavored liquid products containing nicotine that are listed under the 1952 Poisons Act Schedule 1. He made this admission to Judge Elsie Primus in a court hearing.


On January 29th, 2018 at approximately 3pm, Gafoor committed a crime at a well-known electronics store in Segama shopping center. He was charged under Section 13(a) of the 1952 Poison Act and punished accordingly under Section 32(2) of the same law.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in translation ability, the translated article may not express the exact meaning of the original text. Please refer to the original text for accuracy.


2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau, Taiwan or foreign-related positions and statements.


The copyright of the compiled information belongs to the original media and author. If there is a violation, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarette and e-liquid in new draft law, citing dangerous substances found.
Apr.08 by 2FIRSTS.ai
Isle of Wight councillors raise concerns about youth vaping; one says it may be seen “akin to asbestos”
Isle of Wight councillors raise concerns about youth vaping; one says it may be seen “akin to asbestos”
Concerns about the effects of vaping on young people and public health were raised at County Hall, the report said, with Cllr Chris Jarman saying it may one day be viewed as “akin to asbestos.” Jarman cited NHS-related research and a case highlighted by Hull University Teaching Hospitals NHS Trust: a 15-year-old admitted with chest pain and breathing difficulty who reported cannabis use and vaping about 500 puffs per day and was diagnosed via CT with “air leak syndrome.”
Feb.27 by 2FIRSTS.ai
Casey’s, the No. 3 U.S. C-Store Chain, Sees Nicotine Category Shift as Pouches Rise 31% and Vapor 12%
Casey’s, the No. 3 U.S. C-Store Chain, Sees Nicotine Category Shift as Pouches Rise 31% and Vapor 12%
Casey’s General Stores (NASDAQ: CASY) reported accelerating growth in modern nicotine products during its fiscal third quarter ended January 31, 2026. Nicotine pouch sales increased 31% year over year, while vapor products rose 12%. Although cigarette unit sales continued to decline, management stated that the rate of decline slowed compared to prior quarters.
Market
Mar.15
France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts
France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts
2Firsts has learned that France’s national health authority, the Haute Autorité de Santé (HAS), confirmed the role of e-cigarettes will be addressed in updated national smoking-cessation guidelines expected by the end of 2026. HAS said the recommendations will focus on clinical and public-health considerations, will not set technical standards for vaping products, and that current studies are insufficient to clearly assess risks and benefits across different product categories.
Mar.10
Turkey’s New Tobacco Bill Draft Would Cover E-Cigarettes and Heated Tobacco Products
Turkey’s New Tobacco Bill Draft Would Cover E-Cigarettes and Heated Tobacco Products
A Turkey’s draft would impose major limits on the use of tobacco products in public buildings, educational and healthcare institutions, children’s areas, and outdoor events, while setting a 2040 target for a complete ban on the production, sale, and consumption of tobacco products. The draft also broadens the definition of tobacco products to include e-cigarettes, heated tobacco products, and all nicotine-containing systems.
Apr.13 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02